Natural and synthetic compounds in Ovarian Cancer: A focus on NRF2/KEAP1 pathway

G Tossetta, D Marzioni - Pharmacological Research, 2022 - Elsevier
Among gynecologic malignancies, ovarian cancer is one of the most dangerous, with a high
fatality rate and relapse due to the occurrence of chemoresistance. Many researchers …
被引用次数：57 相关文章

Natural and synthetic compounds in Ovarian Cancer: A focus on NRF2/KEAP1 pathway

G Tossetta, D Marzioni - Pharmacological research, 2022 - pubmed.ncbi.nlm.nih.gov
Among gynecologic malignancies, ovarian cancer is one of the most dangerous, with a high
fatality rate and relapse due to the occurrence of chemoresistance. Many researchers …

Natural and synthetic compounds in Ovarian Cancer: A focus on NRF2/KEAP1 pathway

G Tossetta, D Marzioni - PHARMACOLOGICAL RESEARCH, 2022 - iris.univpm.it
Among gynecologic malignancies, ovarian cancer is one of the most dangerous, with a high
fatality rate and relapse due to the occurrence of chemoresistance. Many researchers …

[引用][C] Natural and synthetic compounds in Ovarian Cancer: A focus on NRF2/KEAP1 pathway

G Tossetta, D Marzioni - Pharmacological Research, 2022 - cir.nii.ac.jp
Natural and synthetic compounds in Ovarian Cancer: A focus on NRF2/KEAP1 pathway | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …

Natural and synthetic compounds in Ovarian Cancer: A focus on NRF2/KEAP1 pathway.

G Tossetta, D Marzioni - Pharmacological Research, 2022 - europepmc.org
Among gynecologic malignancies, ovarian cancer is one of the most dangerous, with a high
fatality rate and relapse due to the occurrence of chemoresistance. Many researchers …